p la n (The b ro k en line from N x are th e projectio n s of 2-9 A h y d ro g en bonds. T he sm all sh ad ed circles in d icate th e positions of th e side-chains p ro jec tin g below th e p ep tid e b ack-bone, w hich is show n d iag ra m m a tic allv b y th e u n b ro k en stra ig h t lines. O nly N l5 C2 an d C3 of th e indole m olecule are show n.) elevation F ig u r e 2. In dole a n d a n a-folded p ro tein . (C ovalent rad ii, th ic k circles, h av e been ta k e n as O'7 A a n d v a n de W aals radii, th in circles, as T 5 A. H y d ro g en ato m s h av e been om itted .)
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B y F . L. R o s e
Technical difficulties associated with the complex life cycle of the malaria parasite constitute a major impediment in studies of its enzyme composition. Yet such studies have been developed to a remarkable extent during recent years by the use of human, avian and monkey species of parasite, working in particular with the erythrocytic phases either in, or free from the host red cells, or in cell extracts, and it has been concluded th at in many important instances, for example, in its utiliza tion of glucose, the metabolism of the organism conforms to a pattern common among living cells. It is not surprising, therefore, th at attempts to explain the mechanism of action of anti-malarial drugs should be based on the concept of the competitive inhibition of known enzyme reactions by substances structurally related to the substrate, or product, or to enzymic prosthetic groups.
This communication is concerned mainly with the structural relationships which are apparent in varying degrees between riboflavin and certain anti-malarial sub stances, and the anomalies which arise when these relationships are later applied to drugs of the diguanide class.
Oerstelin (1936) was the first to suggest th at mepacrine and pamaquin, by virtue of their ability to form hydro-derivatives, might act by interference with the functioning of a riboflavin nucleotide component of some enzyme essential to growth. Silverman & Evans (1944) have shown that the bacteriostatic action of mepacrine on B. coli is reduced by a number of substances, including riboflavin, and drew attention to the structural similarity of these compounds. In addition, they showed th at cultures of the bacillus resistant to mepacrine possessed increased resistance to quinine, suggesting a common point of attack for the two drugs. Johnson & Lewin (1945) also found that the growth-inhibitory action of quinine on the same test organism, exhibited over a narrow range of concentration, was reversed by riboflavin as well as by crude cozymase. Similar results were obtained independently by Madinaveitia (1946 a) working with Lactobacillus casei.
A prima facie case can be made out, therefore, for mepacrine and quinine riboflavin antagonists, at any rate so far as bacterial growth is concerned. Studies on the respiration of mammalian tissue by Wright & Sabine (1944) and Haas (1944) further demonstrated th at mepacrine, and, to a lesser extent, quinine, interfered with the yellow enzyme systems, and it was proposed that the drugs might act by competing with flavin nucleotides for one or more essential proteins. Hellerman, Lindsay & Bovarnick (1946) confirmed these findings but pointed out that the nucleotide-inhibitor antagonism was not at all specific for anti-malarial substances, but was readily detectable with a variety of other non-anti-malarial quinolines, and indeed with such simple compounds as aniline, at higher concentrations.
Biochemical experiments with the malaria parasite itself cannot be said to implicate the flavin enzyme systems as immediately susceptible to the anti-malarial drugs. Christophers & Fulton (1938) were the first to point out that quinine, mepacrine and pamaquin, suppressed the rapid oxygen consumption of parasitized monkey blood ( Plasmodium, J c n o w l e s i ) in the presence of gluc were observed by Coggeshall & Maier (1941), and Silverman, Ceithmal, Taliafero & Evans (1944) . I t was obviously desirable to extend these experiments to parasites separated from red blood cells, especially from nucleated red cells. Christophers & Fulton (1939) showed th at haemolysates of parasitized monkey blood retained both infectiveness and some degree of respiration in the presence of glucose. More recently, Speck & Evans (1945) prepared suspensions of P. gallinaceum from chicken blood and investigated the action of quinine and mepacrine on some of the glycolytic enzymes thereof, and Bovarnick, Lindsay & Hellerman (1946) experi mented similarly with P. lophurae from the red cells of parasitized duck blood. In no case did the results provide evidence for the view th at mepacrine acts specifi cally against flavin enzymes directly associated with the parasite; indeed, some of the affected enzymes quite definitely did not belong to this chemical class. It should be noted, however, th at the presence of flavin adenine dinucleotides has indeed been reported in erythrocytes parasitized with knowlesi (Evans 1946 ). An additional difficulty arises from the inability to differentiate with certainty between inhibitory processes which may be either primary or secondary to the lethal action of the anti-malarial drugs, i.e. concerned directly with the parasite, or with the cells of the host, A further criticism that can be made against the interpretation of much of the data available is th at in many cases the drug concentrations required to produce inhibition of enzyme activity in vitro bear little relationship to those th at must obtain in the treatm ent of either experimental or clinical malaria, although Ball (1946) and his collaborators claim th at in their work with knowlesi the same concentrations of quinine and mepacrine were required to suppress growth both in vitro and in vivo. Here, then, in this inconclusive state, the biological aspects of the problem must be left, and attention be given to the chemical evidence th at might support the association of anti-malarial activity with riboflavin. Clearly, the final answer can only be given by a biological experiment, but the demonstration in vitro of anti-bacterial activity of a type antagonized by riboflavin and then of anti-malarial activity in v i v o , with a sufficient number of distinct chemic each bearing some structural similarity to the vitamin might nevertheless be accepted for the time being as strong circumstantial evidence in favour of the hypothesis, and if accepted by the biologist and biochemist, should encourage them to seek the final proof.
The antagonism between riboflavin (I) and the anti-malarial drugs, mepacrine (II), quinine (III) and pamaquin (IV), with respect to the growth of Lactobacillus casei and other bacteria has already been referred to.
Of these compounds, it can be argued th a t mepacrine bears the closest formal structural resemblance to the vitamin in th a t both contain a tricyclic system, similarly constituted in part, and each carries a side-chain attached to the ring system at equivalent positions.
The biochemical antagonism might then be due to one or more of the major differences in detail. These include the inherent chemical differences such as reducibility, between the acridine and isoalloxazine ring systems; the substitution of chlorine for the two methyl groups, which is significant in view of the observation made by Kuhn, Weygand & Moller (1943) that the 6:7-dichloro analogue (V) of riboflavin is a potent inhibitor of this substance with respect to bacterial grow th; and finally, as pointed out by Madinaveitia (private communication), the opposite terminal ionic charge on the side-chain of the drug compared with th at of the vitamin in its phosphorylated (mononucleotide) form.
The structural relationship between quinine, pamaquin, and riboflavin is less obvious and cannot justify argument beyond the point th at both of the drugs can be regarded as containing a methoxyquinoline system in common with mepacrine.
The more recently discovered anti-malarial anilinopyrimidines developed in these laboratories also function as riboflavin antagonists when examined with respect to Lb. casei (Madinaveitia 1946 a) , and, in addition, are less anti-bacterial to strains of B. coli which have become adapted to mepacrine, suggesting a common point of attack on this organism (Madinaveitia, private communication). These new sub-stances do not possess the three-ring system of riboflavin, but one type (VI) can at least be formulated as a planar structure, containing benzene and pyrimidine nuclei linked through nitrogen and similarly disposed to those in the vitamin, but with the basic side-chain necessarily occupying a position not exactly equivalent to that of the ribityl group. It might, indeed, be argued th at the only function of the alkylaminoalkyl side-chain in this and other potent anti-malarial substances is to provide, by reason of its strongly basic properties, the necessary pharmacological features to enable the drugs to gain access to the malaria parasite. In this event the coinci dence of its position in mepacrine with th at of the ribityl group in riboflavin would be considered of little significance as the basis of antagonism, which would then be due essentially to the substitution of the chloroacridine structure for the dimethylisoalloxazine nucleus. In the same way, disregarding the basic side-chain, it might be more justifiable to consider (VI) formulated as in (Via) in relation to riboflavin as drawn in (I), the chloroanilinopyrimidyl grouping functioning as the sole toxophoric system. The chlorine substituent, which is essential for marked anti-malarial activity, now occupies a relative position similar to that of mepacrine (II).
The second class of anilinopyrimidines, in general of greater therapeutic potency than (VI), is that typified by (VII).
This substance also markedly inhibits the growth of bacteria, and the inhibition is annulled by the addition of riboflavin to the culture medium. The chlorine atom is again an essential component for highest anti-malarial (and anti-bacterial) activity, and if a structural similarity to riboflavin is sought, then it must be on the basis of the correspondence of the chlorophenyl residue of the former with the xylyl residue of the latter, and of the portion of the drug shown between the dotted lines with the pyrimidine ring of the vitamin.
Finally, an important chemical link in the hypothesis relating anti-malarial structure to the antagonism of some flavin system, is provided by the synthesis by Dr H. R. Ing (private communication; detailed results to be published shortly) of compounds such as (VIII). In these, the isoalloxazine system of the growth factor has been retained, but as in (V) the 6:7-methyl groups have been replaced by 6:7-dichloro substituents and the carbohydrate group by a basic side-chain. The resultant molecule has been shown by Madinaveitia in these laboratories to be a riboflavin antagonist with respect to the growth of Lactobacillus casei, and by Davey to possess therapeutic activity against a Plasmodium, gallinaceum infection in chicks.
The diguanide anti-malarial drug proguanil (' Paludrine ') was derived on the basis of purely chemical reasoning made clear by comparison of its structure, when formu lated in the unconventional form (IX) with mepacrine (II), and in particular with its immediate precursor (Via). Yet Madinaveitia (19466) has shown th at the anti bacterial action of this substance is not affected by added riboflavin in the culture medium, and in addition it is generally considered that quantitatively, and qualita tively, its therapeutic action in malaria is quite distinct from th at of the earlier drugs. So far no explanation based on biological and biochemical research has been advanced to account for these differences. This led Curd & Rose (1947) to make proposals, based on chemical structure concepts, which they considered might merit consideration. A characteristic of (IX), and of diguanides in general, is the capacity to combine with metals, in particular with copper, to form derivatives which are undoubted co-ordination complexes. That between (IX) and copper might be expected to have the empirical structure (X) in accord with analytical data. Molecular models showed that in the planar form (XI) this complex should possess considerable stability, and the formal resemblance of this molecule to those of the porphyrin group e.g. (XII) led to the initial prediction th at proguanil might exert its biological effects through the production in vivo of a metal complex which would then interfere with a porphyrin-containing system associated with the malaria parasite. The most striking features of this structural similarity are considered to be the six-membered rings in which the metal atoms are chelated, the simulation of the The idea of a drug interfering with the utilization of an essential metabolite is older than the subject of chemotherapy itself, and probably celebrated its fiftieth birthday about a month ago. In 1898 Ehrlich, in a letter to his cousin Carl Weigert, indicated clearly the conception which has attracted so much attention in recent years. In his example Ehrlich pictured, for the sake of argument, an aldehyde group protruding from a cell having the particular function of fixing a specific nutritional factor for that cell. He then pictured a harmless compound, circulating in the blood, having the property of combining with this aldehyde group and so rendering the latter unavailable for its normal role. He goes on to say th at the cell in this specific way must go hungry and can only survive if it can throw out another side-chain carrying an aldehyde group (Heymann 1928) . In modern nomenclature,
